Clark George C.
VP, Chief Accounting Officer at Biohaven Pharmaceutical Holding Co Ltd.
- Sold, on record
- $1.9M
- Dollars the filings state
- Form 4 sales
- 3
- Latest May 10, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Biohaven Pharmaceutical Holding Co Ltd.VP, Chief Accounting Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedDec 20, 2021 2021
Sold 1,915 shares at $123.84 ($237k)
Clark George C., VP, Chief Accounting Officer
Sold 18.9% of holdings ($1.3M position)8,240 shares leftFirst sale on recordFiling
- 2 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJan 19, 2022 +30 days
Sold 9,375 shares at $117.01 ($1.1M)
Clark George C., VP, Chief Accounting Officer
Sold 60.9% of holdings ($1.8M position)6,015 shares leftFiling
- 3 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualMay 10, 2022 +111 days
Sold 4,200 shares at $141.50 ($594k)
Clark George C., VP, Chief Accounting Officer
Sold 50.8% of holdings ($1.2M position)4,065 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2022 | May 12, 2022 | Biohaven Pharmaceutical Holding Co Ltd. | VP, Chief Accounting Officer | Form 4 sale | 4,200 | $594k | 50.8% | Unusual | SEC |
| Jan 19, 2022 | Jan 24, 2022 | Biohaven Pharmaceutical Holding Co Ltd. | VP, Chief Accounting Officer | Form 4 sale | 9,375 | $1.1M | 60.9% | Unusual | SEC |
| Dec 20, 2021 | Dec 22, 2021 | Biohaven Pharmaceutical Holding Co Ltd. | VP, Chief Accounting Officer | Form 4 sale | 1,915 | $237k | 18.9% | Plan not stated | SEC |